|
Active substance |
lumacaftor/ivacaftor |
|
Holder |
Parexel |
|
Status |
Closed |
|
Indication |
Cystic fibrosis in patients 12yrs and older who are homozygous for the F508del CFTR mutation |
|
Public documents |
|
|
Last update |
06/03/2017 |
Orkambi®
Last updated on 13/09/2024